Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis.

Macrolides were not associated with an elevated risk of acute cardiac events compared to ICS. The increased risk of hearing loss in macrolide users compared to ICS users in older bronchiectasis patients should be balanced against known benefits of macrolides.